E-LIB Suche - Ergebnisse für: Mellinghoff, Ingo

1

LGG-60. DISTRIBUTION AND CLINICAL SIGNIFICANCE OF FGFR ALTE..:

Nobre, Liana ; Farouk, Sameer ; Larsen, Alexandra...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

2

OTHR-26. MINIMALLY-INVASIVE MOLECULAR DIAGNOSIS OF DIFFUSE ..:

Larsen, Alexandra M Giantini ; Hill, Katherine ; Hickman, Richard...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

3

LGG-20. LANDSCAPE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA ..:

Nobre, Liana ; Sait, Sameer Farouk ; Bennet, Julie...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i60-i60 , 2023

Link: https://doi.org/10.1093/..

4

LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR ..:

Wen, Patrick ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v310-v311 , 2023

Link: https://doi.org/10.1093/..

5

CTIM-05. RESULTS OF SAFETY LEAD IN OF PHASE II TRIAL OF COM..:

Fortunato, John ; Newton, Adam ; Gonzalez, Ashley...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v61-v61 , 2023

Link: https://doi.org/10.1093/..

6

CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASID..:

Cloughesy, Timothy ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v86-v87 , 2023

Link: https://doi.org/10.1093/..

7

NIMG-38. TUMOR VOLUME GROWTH RATES AND DOUBLING TIMES DURIN..:

Bhatia, Ankush ; Moreno, Raquel ; Reiner, Anne...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v194-v194 , 2023

Link: https://doi.org/10.1093/..

8

METB-07. MINIMALLY-INVASIVE DIAGNOSIS OF DIFFUSE LEPTOMENIN..:

Larsen, Alexandra Giantini ; Hill, Katherine ; Hickman, Richard...
Neuro-Oncology. 25 (2023) Supplement_1 - p. i31-i31 , 2023

Link: https://doi.org/10.1093/..

9

CTIM-14. PHASE 1 SAFETY LEAD-IN AND RANDOMIZED OPEN-LABEL P..:

Wen, Patrick ; Peters, Katherine ; de la Fuente, Macarena...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v64-v64 , 2023

Link: https://doi.org/10.1093/..

10

CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND R..:

Wen, Patrick ; Alexander, Brian ; Berry, Donald...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v97-v98 , 2023

Link: https://doi.org/10.1093/..

11

MODL-37. MODELING REVERSIBLE TUMORIGENESIS IN CEREBRAL ORGA..:

Graham, Maya ; Codega, Paolo ; Campos, Carl...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v307-v307 , 2023

Link: https://doi.org/10.1093/..

12

Clinical, histological, and molecular features of gliomas i..:

Romo, Carlos G ; Piotrowski, Anna F ; Campian, Jian L...
Neuro-Oncology. 25 (2023) 8 - p. 1474-1486 , 2023

Link: https://doi.org/10.1093/..

13

QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASID..:

Peters, Katherine ; Mellinghoff, Ingo ; van den Bent, Martin...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v254-v255 , 2023

Link: https://doi.org/10.1093/..

14

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE..:

Rahman, Rifaquat ; Trippa, Lorenzo ; Fell, Geoffrey...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v76-v77 , 2023

Link: https://doi.org/10.1093/..

15

PATH-27. DROPLET DIGITAL PCR ENHANCES DETECTION OF HOTSPOT ..:

Tartaro, Marlene ; Nandakumar, Subhiksha ; Hertz, Charli Ann...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v173-v173 , 2023

Link: https://doi.org/10.1093/..